These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 17049989)

  • 1. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis.
    Tan Y; Zhou W; Yu F; Fang Q; Yang HZ; Zhao MH
    Mol Immunol; 2009 Jul; 46(11-12):2178-82. PubMed ID: 19481805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus nephritis sera contain autoantibodies that recognize epitopes within the globular fragment of C1q.
    Deliyska B; Tsacheva I; Radanova M; Stoianova V; Tchorbadjieva M; Dobreva N
    Med Pregl; 2007; 60 Suppl 2():25-7. PubMed ID: 18928152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
    Radanova M; Vasilev V; Deliyska B; Kishore U; Ikonomov V; Ivanova D
    Immunobiology; 2012 Jul; 217(7):684-91. PubMed ID: 22209113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insight into the autoimmunogenicity of the complement protein C1q.
    Stoyanova V; Petrova S; Tchorbadjieva M; Deliyska B; Vasilev V; Tsacheva I
    Mol Immunol; 2011 Jan; 48(4):678-82. PubMed ID: 21159384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
    J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
    Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.
    Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M
    J Immunol; 2009 Dec; 183(12):8225-31. PubMed ID: 20007586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
    Cook AD; Rowley MJ; Wines BD; Mackay IR
    J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA.
    Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B
    J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
    Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.